cyclosporine has been researched along with Hepatitis B, Chronic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 7 (46.67) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, G; Pei, Y; Wang, C; Yan, SF | 1 |
| Bitetto, D; Bulajic, M; Cmet, S; Cussigh, A; Fabris, C; Falleti, E; Toniutto, P; Vadalà, S; Zilli, M | 1 |
| Feng, R; Fu, HX; Hu, JD; Huang, XJ; Jiang, H; Jiang, M; Jiang, Q; Liu, H; Ma, H; Niu, T; Wang, H; Wang, JW; Wang, X; Wang, Z; Wei, L; Xie, YD; Xu, LP; Zhang, XH; Zhu, XL | 1 |
| Cai, H; Cao, X; Chen, M; Duan, M; Han, B; Li, J; Wang, S; Xu, Y; Zhang, W; Zhao, Y; Zhou, D; Zhu, T; Zhuang, J | 1 |
| Alavian, SM | 1 |
| Li, L; Liu, J; She, W; Tian, X; Wen, YM; Xie, Y; Zhang, J; Zhao, C; Zheng, S; Zhu, H | 1 |
| Chang, CH; Chen, JH; Fang, YW; Tsai, MS; Yang, AH | 1 |
| Daoudaki, M; Dimou, V; Fouzas, I; Fylaktou, A; Mavrovouniotis, I; Papanikolaou, V; Papaventsis, D; Sianou, E | 1 |
| Chao, TY; Dai, MS; Kao, WY; Shyu, RY | 1 |
| Shen, Y; Xia, WL; Zheng, SS | 1 |
| Krawczuk-Rybak, M; Lebensztejn, DM; Luczyński, W; Muszyńska-Rosłan, K | 1 |
| Bianchi, L; Campione, E; Chimenti, S; Diluvio, L; Giorgetti, G; Paternò, EJ | 1 |
| Andreone, P; Bernardi, M; Bertoletti, A; Bihl, F; Biselli, M; Brander, C; Chisholm, JV; Cursaro, C; Loggi, E; Morelli, MC; Terrault, NA | 1 |
| Han, DJ; Jung, YO; Lee, YS; Park, JS; Park, SK; Yang, WS | 1 |
| Bernard, B; Bitker, MO; Coriat, P; Mouquet, C; Opolon, P; Poynard, T; Thibault, V | 1 |
2 review(s) available for cyclosporine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
Topics: Antiviral Agents; B7-H1 Antigen; Biological Products; Drug Repositioning; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HSC70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Nucleocapsid; Oligonucleotides, Antisense; Programmed Cell Death 1 Receptor; Ribonuclease H; RNAi Therapeutics; Toll-Like Receptors; Virus Internalization; Virus Replication | 2017 |
Inhibitory effect of cyclosporine A on hepatitis B virus replication in vitro and its possible mechanisms.
Topics: Calcium Signaling; Cyclosporine; Hepatitis B virus; Hepatitis B, Chronic; Humans; In Vitro Techniques; Mitochondria; Sensitivity and Specificity; Severity of Illness Index; Virus Replication | 2005 |
2 trial(s) available for cyclosporine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.
Topics: Adult; Blood Coagulation Tests; China; Cyclosporine; Drug Therapy, Combination; Female; Hemorrhage; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Nucleosides; Platelet Count; Prednisone; Severity of Illness Index; Thrombocytopenia; Treatment Outcome; Virus Replication | 2015 |
Treatment of chronic hepatitis B with lamivudine in renal transplant recipients.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Creatinine; Cyclosporine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Male; Reverse Transcriptase Inhibitors; Virus Replication | 1998 |
11 other study(ies) available for cyclosporine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Biliary strictures after liver transplantation: role of interleukin 28B genotypes in cyclosporine treated.
Topics: Adult; Aged; Anastomotic Leak; Cholestasis; Cyclosporine; Female; Genetic Variation; Genotype; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferons; Interleukins; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Risk Factors; Tacrolimus | 2014 |
Outcome of anti-thymocyte immunoglobulin plus cyclosporine A for severe aplastic anaemia with chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Anemia, Aplastic; Antilymphocyte Serum; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Re: posttransplant diabetes mellitus in kidney allograft recipients at Shaheed Hasheminejad Hospital.
Topics: Cyclosporine; Diabetes Mellitus, Type 2; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation | 2008 |
Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cells, Cultured; Cyclophilin A; Cyclosporine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Virus Replication | 2010 |
Membranous nephropathy induced by pegylated interferon alpha-2a therapy for chronic viral hepatitis B.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Biopsy; Cyclosporine; Drug Substitution; Glomerulonephritis, Membranous; Guanine; Hepatitis B, Chronic; Humans; Immunohistochemistry; Immunosuppressive Agents; Interferon-alpha; Kidney; Male; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Treatment Outcome | 2012 |
Hepatitis B reactivation in a renal transplant patient due to a surface antigen mutant strain: a case report.
Topics: Antibodies, Monoclonal, Murine-Derived; Base Sequence; Biomarkers; Cyclosporine; DNA Mutational Analysis; DNA, Viral; Drug Therapy, Combination; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Molecular Sequence Data; Mutation; Mycophenolic Acid; Prednisolone; Rituximab; Treatment Outcome; Viral Load; Virus Activation | 2012 |
Restoration of immunity and reactivation of hepatitis B virus after immunosuppressive therapy in a patient with severe aplastic anaemia.
Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Antiviral Agents; Carrier State; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Recurrence | 2004 |
[Immunotherapy in aplastic anaemia as a cause of reactivation of hepatitis B virus-immunologic aspects].
Topics: Anemia, Aplastic; Antigens, CD; Antiviral Agents; Child; Combined Modality Therapy; Cyclosporine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Immunotherapy; Interferon-alpha; Lamivudine; Male; Reverse Transcriptase Inhibitors | 2005 |
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B.
Topics: Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Middle Aged; Skin; Tacrolimus | 2008 |
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Topics: Antibody Specificity; Cyclosporine; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphocytes; Nucleocapsid; Recurrence; T-Lymphocytes; Tacrolimus; Viral Load | 2008 |
Chronic hepatitis B treatment with lamivudine in kidney transplant patients.
Topics: Adult; Antiviral Agents; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Kidney Transplantation; Lamivudine; Liver Function Tests; Postoperative Complications; Retrospective Studies | 2000 |